AIDX 20/20 Biolabs, Inc.

$0.65 +0.18%

Industrials · Services-Testing Laboratories

20/20 Biolabs, Inc. (AIDX) is a industrials company in the Services-Testing Laboratories industry, with a market capitalization of $7 million. Shares last traded at $0.65, 98.1% below their 52-week high.

Market Cap

$7M

Shares Out

10.6M

EPS (TTM)

—

P/E Ratio

—

P/S Ratio

—

P/B Ratio

—

Dividend / Share

—

Dividend Yield

—

52-Week High

$35.00

52-Week Low

$0.54

Volume

3,633

Avg Vol (3m)

17,897.635

Performance

-24.37%

-52.53%

-67.15%

—

YTD

-97.26%

—

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

27.08

SMA (50)

$1.29

SMA (200)

—

Price vs SMA50

-49.49%

Price vs SMA200

—

ATR (14)

$0.16

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.28	2026-05-20
FY 2025	$-0.76	2026-03-31
Q1 2026	$-0.16	2026-05-20
FY 2025	$-1.16	2026-03-31

Full earnings history →

Services-Testing Laboratories peers

AIDX vs 4 industry peers (Services-Testing Laboratories), by market cap.

1–4 of 4


ULS	Ul Solutions Inc.	$18.4B	—	—	—	-2.88%
NEO	Neogenomics Inc	$1.4B	-13.43	1.99	-14.8%	+7.17%
AIDX	20/20 Biolabs, Inc.	$7M	—	—	—	+0.18%
BNBX	BNB PLUS CORP.	$3M	-0.21	—	—	-6.58%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.